Credit: Pixabay/CC0 Public Domain Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions
Credit: Unsplash/CC0 Public Domain Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only the culprit artery causing the heart attack according to a new, large international study led
MedPage Today) — Former Vice President Dick Cheney battled heart disease for most of his adult life, a life extended thanks in part to a heart transplant in 2012. Cheney, who died Monday due to complications of pneumonia and cardiac and vascular…
For patients with cardiac arrest and a shockable rhythm, automated external defibrillators (AEDs) in private homes improve outcomes but cannot be considered cost-effective at current pricing, according to a study published online Oct. 25 in JAMA Internal Medicine to coincide with the European Resuscitation Council Congress…
Credit: Pixabay/CC0 Public Domain David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter’s Advanced Heart & Vascular Service Line, presented results of the international ENCIRCLE clinical trial at the Transcatheter Cardiovascular Therapeutics conference in San Francisco, Calif. The findings were simultaneously published in The Lancet
MedPage Today) — Having an automatic external defibrillator (AED) in a private home does appear to increase the likelihood of survival in people who experience certain types of cardiac arrest, but having them in all private homes is not currently…
Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition that affects babies born to mothers with specific autoantibodies—called anti-SSA/Ro antibodies—which can attack the fetal heart via its electrical conduction system, leading to a slower heart rate. Most surviving infants with congenital heart block eventually require a pacemaker
TOPLINE: Adults aged 40 years or older presenting to the emergency department (ED) with presyncope (near-fainting) or syncope (fainting) had similar rates of 30-day serious cardiac outcomes (5.2% vs 4.7%), although physicians estimated a higher risk for patients with syncope during their ED assessments. METHODOLOGY: Researchers conducted a secondary analysis of a prospective…
People who have a cardiac arrest in their own homes have similar neurological outcomes regardless of socioeconomic background, according to research presented at the European Emergency Medicine Congress…
Credit: Pixabay from Pexels A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to action for managing cardiogenic shock (CS), establishing lactate clearance potentially as the standardized, time-based marker of patient trajectory to improve outcomes in one of the deadliest cardiovascular emergencies. “SCAI Door to Lactate